https://notch-receptor.com/ind....ex.php/covid-19-an-i
g., melatonin, mercaptopurine, and sirolimus) that are additional validated by enrichment analyses of drug-gene signatures and HCoV-induced transcriptomics data in person mobile lines. We further identify three potential medicine combinations (age.g., sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) grabbed because of the "Complementary Exposure" pattern the targets associated with medications both hit the HCoV-host subnetwork, but target indiv
Like
Comment
Share
